###### What is already known on this topic?

-   The EPICure studies found survival of extremely preterm infants admitted to neonatal care in England to improve from 1995 to 2006.

-   We identified no nationwide assessment of preterm survival following neonatal care since that time. This is likely to reflect the difficulties and costs of large-scale data collection.

###### What this study adds?

-   Our study shows that survival of preterm infants admitted to neonatal care has continued to improve, particularly for infants of the lowest gestations. However we also identified regional variation that is not explained by patient characteristics.

-   Improvements have not been consistent across the country, warranting further investigation into the reasons for variation.

-   As large, population-based studies are required to detect unusual variation in patient outcomes, electronic patient records provide opportunity to conduct such studies efficiently.

Introduction {#s1}
============

Preterm birth is the primary cause of neonatal death worldwide and carries lifelong risks to health.[@R1] Population, as opposed to hospital-based data, is essential to obtain an unbiased picture of survival, but undertaking such studies can be challenging and expensive.[@R3] National data are also required to assess regional variation, a necessary step to identifying areas for improvement and reducing health inequalities.

The National Neonatal Research Database (NNRD) is a repository of a predefined set of variables (the Neonatal Data Set; National Health Service (NHS) Information Standard SCCI1595), extracted quarterly from clinician-entered, point-of-care electronic patient records (EPR) for all infants admitted to neonatal units in England, Wales and Scotland.[@R4] Data are cleaned (eg, assessed for duplicates and inconsistencies), potential errors are checked with clinical teams and multiple episodes merged to create a single patient record.

We evaluated trends in survival for infants born 22^+0^--31^+6^ weeks' gestation and admitted to neonatal units in England 2008--2014. We assessed regional variation and relationship with socioeconomic deprivation. We examined survival trends over a 20-year period for those born at the earliest gestations by including previously published data. The secondary aims were to examine 28-day survival and postnatal age at death and develop a statistical model to predict survival.

Methods {#s2}
=======

We extracted NNRD data for infants born January 2008--December 2014 from 22^+0^--31^+6^ weeks^+days^ gestational age (GA) and admitted to a neonatal unit in England (data from Scotland and Wales were unavailable in 2008). The NNRD is approved by the National Research Ethics Service (16/LO/1093) and the Caldicott Guardians of contributing NHS Trusts. Approval is held from the Confidentiality Advisory Group of the Health Research Authority to hold NHS numbers for linkage (ECC8-05(f)/2010).

Data comprised GA (the best obstetric estimate, initially based on last menstrual period and modified by antenatal ultrasound), birth weight (BW), singleton/multiple pregnancy, administration of antenatal steroids, vaginal/caesarean delivery, maternal age, maternal ethnicity, smoking during pregnancy and Index of Multiple Deprivation (IMD) 2010 quintile based on lower super output area (LSOA) rank.[@R5] We identified small-for-gestational age infants (BW \<10th centile for gestation), calculated BW SD score (UK-WHO preterm growth reference[@R6]), and excluded infants with BW greater than 4SD from the gestation and sex-specific mean as we considered these potentially erroneous. Outcomes were determined from discharge data.

To reduce missing data we linked the NNRD to UK Office of National Statistics-Hospital Episode Statistics (ONS-HES) data. ONS-HES data were used for 28-day survival only as we could not ascertain if death occurred in neonatal care. Data extraction and linkage were carried out using SAS V.9.3.

Statistical analysis {#s2a}
--------------------

We estimated time trends for survival to discharge and 28 days using joinpoint regression.[@R7] We used joinpoint regression to enable detection of any changes in survival trends. Joinpoint regression allows the number and location of the change points to be unknown and determines which change points, if any, fit the data best. The minimum and maximum number of joinpoints that could be selected was 0 and 5, respectively. We log-transformed rates; hence, trends are presented as annual percentage change (APC), the annual rate of change of the survival rate. We directly standardised survival rates for risk of death,[@R9] grouping infants into 10 risk categories, each with an equal number of predicted deaths. The risk of death was calculated using logistic regression, including established clinical risk factors (GA, BW, sex, singleton/multiple pregnancy, any antenatal steroids (no/yes)).[@R11] Online [supplementary file 1](#SP1){ref-type="supplementary-material"} material shows the full methods including assessment of model fit.
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We checked for seasonality by varying the autocorrelation parameter. As the number of neonatal units contributing data increased over time, we analysed complete neonatal networks as a sensitivity analysis. We tested for differences in postnatal age at death using quantile regression.

We restricted the regional analysis to 2011 onwards in view of the possibility that lower population coverage in earlier years might bias regional estimates. Infants were assigned to one of the four regions (London, Midlands and East of England, North of England and South of England) based on mothers' residence. We calculated crude and standardised rates of survival to discharge and trends in crude survival; standardised trends by region were not calculated due to low numbers. We calculated crude and standardised rates of survival to discharge for the highest and lowest IMD quintile and computed the risk difference (RD). We added region (categorical) and IMD decile (continuous) to the risk adjustment model to test for residual regional variation.

We compared NNRD data with published data for England. First we used joinpoint regression to compare recent trends in the NNRD data (2008--2014) with previous estimates from the EPICure studies[@R12] (1995 and 2006). EPICure 199[@R12] involved all deliveries at 20^+0^--25^+6^ weeks^+days^ GA in March--December 1995 in every maternity unit in the UK and Ireland. EPICure 2[@R13] provided information on all babies born 20^+0^--25^+6^ weeks^+days^ GA in England in 2006. Only infants admitted to neonatal care in England were included.

Second, we compared the number of infants at each GA week by 28-day survival status and region of mother's residence in the NNRD (denominator: neonatal unit admissions) with published ONS data[@R14] (denominator: live births) for infants born at 22^+0^--31^+6^ weeks^+days^ GA. Data were compared for 2013 due to availability of England-only ONS data.

Results {#s3}
=======

Study population {#s3a}
----------------

Data were available for 71% of neonatal units in England for 2008, 80% in 2009, 86% in 2010, 97% in 2011, 99% in 2012 and 100% in 2013 and 2014. There were 50 467 infants born over 2008--2014 at 22^+0^--31^+6^ weeks GA who were admitted to a neonatal unit in England. We excluded 38 babies with implausible BW for GA, and 317 because BW, sex or multiple birth status was missing, leaving 50 112 infants in the study cohort. Population characteristics were broadly similar across all 7 years ([table 1](#T1){ref-type="table"}), although some differences were statistically significant. The 20% most deprived LSOA contributed over 30% of the study population, while the 20% least deprived LSOA contributed 13%.

###### 

Population characteristics for infants born 22^+0^--31^+6^ weeks' gestation, England 2008--2014, and admitted to a neonatal unit contributing to the National Neonatal Research Database

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                      2008\         2009\         2010\         2011\         2012\         2013\         2014\         Total\          p Value for trend
                                                      n=6103        n=6487        n=7386        n=7733        n=7667        n=7367        n=7369        n=50 112        
  ---------------------------------- ---------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- --------------- -------------------
  Gestational age (complete weeks)   22^+0^--22^+6^   14 (0.2)      9 (0.1)       11 (0.1)      9 (0.1)       5 (0.1)       12 (0.2)      8 (0.1)       68 (0.1)        p\<0.01

                                     23^+0^--23^+6^   181(3)        151 (2.3)     187 (2.5)     156(2)        200 (2.6)     186 (2.5)     220(3)        1281 (2.6)      

                                     24^+0^--24^+6^   356 (5.8)     332 (5.1)     358 (4.8)     434 (5.6)     406 (5.3)     384 (5.2)     374 (5.1)     2644 (5.3)      

                                     25^+0^--25^+6^   404 (6.6)     362 (5.6)     401 (5.4)     456 (5.9)     466 (6.1)     458 (6.2)     446 (6.1)     2993(6)         

                                     26^+0^--26^+6^   521 (8.5)     516(8)        589(8)        648 (8.4)     587 (7.7)     567 (7.7)     590(8)        4018(8)         

                                     27^+0^--27^+6^   600 (9.8)     703 (10.8)    717 (9.7)     753 (9.7)     786 (10.3)    671 (9.1)     642 (8.7)     4872 (9.7)      

                                     28^+0^--28^+6^   755 (12.4)    828 (12.8)    966 (13.1)    964 (12.5)    925 (12.1)    913 (12.4)    895 (12.1)    6246 (12.5)     

                                     29^+0^--29^+6^   855(14)       906(14)       1063 (14.4)   1100 (14.2)   1067 (13.9)   1084 (14.7)   1030(14)      7105 (14.2)     

                                     30^+0^--30^+6^   1072 (17.6)   1145 (17.7)   1318 (17.8)   1361 (17.6)   1349 (17.6)   1334 (18.1)   1365 (18.5)   8944 (17.8)     

                                     31^+0^--31^+6^   1345(22)      1535 (23.7)   1776(24)      1852 (23.9)   1876 (24.5)   1758 (23.9)   1799 (24.4)   11 941 (23.8)   

  Birth weight (g)                   \<500            53 (0.9)      47 (0.7)      45 (0.6)      40 (0.5)      52 (0.7)      74 (1.0)      71 (1.0)      382 (0.8)       p=0.74

                                     500--999         2053 (33.6)   2061 (31.8)   2286(31)      2523 (32.6)   2446 (31.9)   2332 (31.7)   2360(32)      16 061 (32.1)   

                                     1000--1499       2519 (41.3)   2811 (43.3)   3209 (43.4)   3310 (42.8)   3297(43)      3148 (42.7)   3160 (42.9)   21 454 (42.8)   

                                     1500--1999       1358 (22.3)   1472 (22.7)   1716 (23.2)   1737 (22.5)   1757 (22.9)   1700 (23.1)   1667 (22.6)   11 407 (22.8)   

                                     ≥2000            120 (2.0)     96 (1.5)      130 (1.8)     123 (1.6)     115 (1.5)     113 (1.5)     111 (1.5)     808 (1.6)       

  Small-for-gestational age          No               5211 (85.4)   5530 (85.2)   6305 (85.4)   6540 (84.6)   6569 (85.7)   6271 (85.1)   6261 (85.0)   42 687 (85.2)   p=0.62

                                     Yes              892 (14.6)    957 (14.8)    1081 (14.6)   1193 (15.4)   1098 (14.3)   1096 (14.9)   1108 (15.0)   7425 (14.8)     

  Sex                                Female           2831 (46.4)   3099 (47.8)   3367 (45.6)   3547 (45.9)   3513 (45.8)   3278 (44.5)   3376 (45.8)   23 011 (45.9)   p=0.01

                                     Male             3272 (53.6)   3388 (52.2)   4019 (54.4)   4186 (54.1)   4154 (54.2)   4089 (55.5)   3993 (54.2)   27 101 (54.1)   

  Multiplicity of pregnancy          Singleton        4456 (73)     4714 (72.7)   5364 (72.6)   5628 (72.8)   5609 (73.2)   5522 (75.0)   5416 (73.5)   36 709 (73.3)   p=0.02

                                     Twins            1514 (24.8)   1626 (25.1)   1828 (24.7)   1889 (24.4)   1852 (24.2)   1675 (22.7)   1777 (24.1)   12 161 (24.3)   

                                     Triplets+        133 (2.2)     147 (2.3)     194 (2.6)     216 (2.8)     206 (2.7)     170 (2.3)     176 (2.4)     1242 (2.5)      

  Any antenatal steroids given       No               738 (12.6)    728 (11.5)    868 (12.1)    864 (11.4)    879 (11.6)    773 (10.6)    766 (10.4)    5616 (11.4)     p\<0.01

                                     Yes              5137 (87.4)   5585 (88.5)   6312 (87.9)   6724 (88.6)   6704 (88.4)   6552 (89.4)   6579 (89.6)   43 593 (88.6)   

                                     *Missing*        228           174           206           145           84            42            24            903             

  Mode of delivery                   Vaginal          2344 (45.2)   2557 (44.1)   2949 (43.6)   3080 (43.1)   3001 (42.6)   2848 (42.2)   2793 (41.1)   19 572 (43.0)   p\<0.01

                                     Caesarean        2843 (54.8)   3246 (55.9)   3817 (56.4)   4070 (56.9)   4044 (57.4)   3896 (57.8)   3996 (58.9)   25 912 (57.0)   

                                     *Missing*        916           684           620           583           622           623           580           4626            

  Maternal age                       \<20             531 (8.9)     520 (8.1)     630 (8.6)     581 (7.5)     527 (6.9)     469 (6.4)     450 (6.2)     3708 (7.5)      p\<0.01

                                     20--24           1088 (18.3)   1201 (18.6)   1342 (18.2)   1498 (19.4)   1390 (18.2)   1248 (17.0)   1175 (16.1)   8942 (18.0)     

                                     25--29           1526 (25.7)   1658 (25.7)   1900 (25.8)   1984 (25.7)   1986 (26.0)   1892 (25.8)   1934 (26.5)   12 880 (25.9)   

                                     30--34           1499 (25.2)   1721 (26.7)   1962 (26.7)   2072 (26.9)   2123 (27.8)   2085 (28.5)   2165 (29.6)   13 627 (27.4)   

                                     35--40           1023 (17.2)   1063 (16.5)   1206 (16.4)   1235 (16.0)   1216 (15.9)   1245 (17.0)   1192 (16.3)   8180 (16.5)     

                                     \>40             270 (4.5)     290 (4.5)     321 (4.4)     335 (4.3)     396 (5.2)     389 (5.3)     386 (5.3)     2387 (4.8)      

                                     *Missing*        166           34            25            28            29            39            67            388             
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Percentages are of the total non-missing values. p Value from non-parametric trend test.

Survival to discharge from 2008 to 2014 {#s3b}
---------------------------------------

Of the 48 422 admitted infants for whom outcomes were known, 43 444 (89.7%) survived to discharge over the whole period. [Table 2](#T2){ref-type="table"} shows the associations between survival and infant characteristics. There was an increase in the percentage of admitted infants who survived to discharge from 88.0% in 2008 to 91.3% in 2014. Survival increased with GA from 17.9% for 22^+0^ to 22^+6^ weeks to 98.1% for 31^+0^--31^+6^ weeks. Crude survival rates were lower for boys, vaginal delivery and infants whose mothers were younger, did not receive antenatal steroids, smoked and came from more deprived areas.

###### 

Survival by population characteristics for infants born 22^+0^--31^+6^ weeks' gestation, England 2008--2014, and admitted to a neonatal unit contributing to the National Neonatal Research Database

                                                        Survived to discharge   Missing               p Value   Survived to 28 days   Missing   p Value                     
  ------------------------------------ ---------------- ----------------------- --------------------- --------- --------------------- --------- --------------------- ----- ----------
  Gestational (age weeks**^+days^**)   22^+0^--22^+6^   12                      17.9 (8.7 to 27.2)    1                               17        25.4 (14.9 to 35.9)   1     
                                       23^+0^--23^+6^   440                     35.9 (33.2 to 38.6)   56                              629       49.6 (46.8 to 52.3)   12    
                                       24^+0^--24^+6^   1464                    58.6 (56.6 to 60.5)   144                             1819      69.6 (67.8 to 71.4)   31    
                                       25^+0^--25^+6^   2091                    74 (72.4 to 75.6)     167                             2421      81.7 (80.3 to 83)     28    
                                       26^+0^--26^+6^   3199                    83.4 (82.3 to 84.6)   184       p\<0.001              3517      88.2 (87.2 to 89.2)   30    p\<0.001
                                       27^+0^--27^+6^   4125                    88.4 (87.5 to 89.4)   208                             4426      91.9 (91.2 to 92.7)   57    
                                       28^+0^--28^+6^   5556                    92.4 (91.7 to 93)     231                             5839      94.5 (93.9 to 95.1)   68    
                                       29^+0^--29^+6^   6599                    95.7 (95.3 to 96.2)   212                             6770      96.6 (96.2 to 97)     95    
                                       30^+0^--30^+6^   8491                    97.5 (97.1 to 97.8)   232                             8621      97.8 (97.5 to 98.1)   128   
                                       31^+0^--31^+6^   11 467                  98.1 (97.9 to 98.4)   255                             11 603    98.4 (98.2 to 98.7)   153   
  Birth weight (g)                     \<500            127                     34.8 (29.9 to 39.7)   17                              192       50.7 (45.6 to 55.7)   3     
                                       500--999         11 748                  76.8 (76.2 to 77.5)   772                             13 256    83.4 (82.8 to 84)     167   
                                       1000--1499       19 918                  95.6 (95.3 to 95.9)   613       p\<0.001              20 431    96.4 (96.1 to 96.6)   259   p\<0.001
                                       1500--1999       10 913                  97.9 (97.7 to 98.2)   262                             11 031    98.1 (97.8 to 98.3)   158   
                                       ≥2000            738                     94.4 (92.8 to 96)     26                              752       94.9 (93.4 to 96.5)   16    
  Small-for-gestational age            No               37 309                  90.4 (90.1 to 90.7)   1406      p\<0.001              38 985    92.5 (92.2 to 92.7)   538   p\<0.001
                                       Yes              6135                    85.9 (85.1 to 86.7)   284                             6677      90.7 (90.1 to 91.4)   65    
  Sex                                  Girls            20 190                  90.6 (90.2 to 91)     732       p\<0.001              21 090    92.8 (92.5 to 93.1)   284   p\<0.001
                                       Boys             23 254                  88.9 (88.6 to 89.3)   958                             24 572    91.7 (91.4 to 92.1)   319   
  Multiplicity of pregnancy            Singleton        31 845                  89.7 (89.4 to 90.1)   1225      p\<0.001              33 506    92.3 (92 to 92.6)     417   p\<0.001
                                       Twins            10 472                  89.3 (88.7 to 89.9)   433                             10 992    91.7 (91.2 to 92.2)   172   
                                       Triplets+        1127                    93.1 (91.7 to 94.6)   32                              1164      94.8 (93.5 to 96)     14    
  Any antenatal steroids given         No               4421                    82.1 (81.1 to 83.2)   233       p\<0.001              4711      85 (84 to 85.9)       72    p\<0.001
                                       Yes              38 327                  90.8 (90.5 to 91)     1369                            40 196    93.2 (93 to 93.5)     485   
  Mode of delivery                     Vaginal          16 346                  85.9 (85.4 to 86.4)   546       p\<0.001              17 275    82.1 (81.1 to 83.2)   190   p\<0.001
                                       Caesarean        23 473                  93 (92.7 to 93.3)     665                             24 367    90.8 (90.5 to 91)     227   
  Maternal age                         \<20             3143                    88.3 (87.2 to 89.3)   147       p\<0.001              3326      90.9 (90 to 91.9)     51    p\<0.001
                                       20--24           7639                    88.5 (87.8 to 89.1)   308                             8063      91.3 (90.7 to 91.9)   108   
                                       25--29           11 268                  90.3 (89.7 to 90.8)   395                             11 821    92.7 (92.2 to 93.1)   122   
                                       30--34           11 890                  90 (89.5 to 90.5)     421                             12 460    92.5 (92.1 to 92.9)   157   
                                       35--40           7171                    90.4 (89.7 to 91)     246                             7505      92.8 (92.2 to 93.3)   89    
                                       \>40             2105                    90.7 (89.6 to 91.9)   67                              2198      93 (91.9 to 94)       23    

Percentages exclude missing. p Value from Χ^2^ tests.

The APC for crude survival was 0.51% (95% CI 0.35 to 0.67, p\<0.001), and after standardisation for risk of death, 0.46% (95% CI 0.30 to 0.62, p\<0.001). Results were similar for all sensitivity analyses.

Trends in survival to discharge by GA {#s3c}
-------------------------------------

[Figure 1](#F1){ref-type="fig"} shows the joinpoint regression analysis for survival to discharge by GA group. Improvements were less marked with increasing GA (22^+0^ to 23^+6^ weeks: APC 6.03% (95% CI 2.47 to 3.53), p=0.002; 30^+0^ to 31^+6^ weeks APC 0.01% (95% CI −0.08 to 0.09), p=0.9).

![Joinpoint regression analysis for crude rates of survival to discharge for admitted infants born at 22^+0^--31^+6^ weeks' gestation by birth year (2008--2014). APC, average percentage change.](fetalneonatal-2017-312748f01){#F1}

Survival to 28 days from 2008 to 2014 {#s3d}
-------------------------------------

Fifty additional deaths were identified by linkage with ONS-HES, of which 20 were within 28 days. There was an increase in the percentage of infants who survived to 28 days from 91.4% in 2008 to 93.5% in 2014. Survival improved with GA (48.4% at 22^+0^ to 23^+6^ weeks to 98.2% at 30^+0^ to 31^+6^ weeks). The APC for crude 28-day survival and after standardisation for risk of death were similar (crude: 0.30% (95% CI 0.15 to 0.45), p\<0.001; after standardisation: 0.27% (95% CI 0.11 to 0.44), p=0.002). The results were also similar when only neonatal networks where all hospitals contributed data for the whole period were examined (crude APC 0.35% (95% CI 0.19 to 0.52); adjusted APC 0.30% (95% CI 0.14 to 0.47)).

Postnatal age at death from 2008 to 2014 {#s3e}
----------------------------------------

Twenty-four per cent of deaths occurred within 24 hours, 28% between 25 hours and 7 days, 26% between 8 days and 28 days, and 23% beyond 28 days. The 75th percentile for postnatal age at death fell from 27.2 days in 2008 to 20.8 days in 2013 but rose to 24.3 days in 2014 (estimated average annual decrease 2008--2014, 0.92 days (95% CI 0.2 to 1.7) p=0.02); there was no evidence of a change in the median and 25th percentile.

Variation by region and IMD quintile using data from 2011 onwards {#s3f}
-----------------------------------------------------------------

Crude survival varied from 89.3% (95% CI 88.6 to 89.9) in the Midlands and East of England to 91.1% (95% CI 90.3 to 91.8) in London; after standardisation the range was 89.2% (95% CI 87.3 to 91.1) to 91.6% (95% CI 89.1 to 94.2). Adjusted survival in the other regions was 90.3 (95% CI 88.0 to 92.5) in the South of England and 89.8 (95% CI 88.0 to 91.8) in the North of England. Only London and the South of England showed improvements in crude survival over 2011 to 2014 (APC: London 1.26% (95% CI 0.60 to 1.96); South of England 1.09% (95% CI 0.36 to 1.82); Midlands and East of England 0.15% (95% CI −0.56 to 0.86); North of England 0.26% (95% CI −0.54 to 1.07)). Infants from the most deprived quintile had lower survival rates compared with those from the least deprived quintile (89.5% (95% CI 88.9 to 90.1) vs 91.1% (95% CI 90.2 to 92.1), RD 1.6% (95% CI 0.5 to 2.7)), but no difference remained after standardisation (89.8% (95% CI 87.9 to 91.5) vs 90.1% (95% CI 87.1 to 93.2), RD 0.3% (95% CI −3.3 to 3.9)). Inclusion of IMD decile in the risk adjustment model did not change results for each region, with evidence of residual variation across regions (p\<0.001 from joint test of region indicators).

Survival to discharge from 1995 to 2014 for extremely preterm infants {#s3g}
---------------------------------------------------------------------

We found improvements in survival to discharge of infants born 22^+0^--25^+6^ weeks^+days^ to have continued at a similar rate across 1995 (EPICure), 2006 (EPICure 2) and 2008--2014 (NNRD). The EPICure studies found that survival increased from 40% in 1995, to 53% in 2006, and based on NNRD data, to 66% (654/992) in 2014. The APC for 1995--2014 was 2.73% (95% CI 2.35 to 3.12), with no evidence for a change in the trend (p=0.25). [Figure 2](#F2){ref-type="fig"} shows trends in gestation-specific survival from 1995 to 2014.

![Survival to discharge for infants born 23--25 weeks and admitted to neonatal units in England in 1995 (EPICure; triangle symbol), 2006 (EPICure 2; cross symbol) and 2008--2014 (NNRD; circle symbol). APC, average percentage change; NNRD, National Neonatal Research Database; NNU, neonatal unit.](fetalneonatal-2017-312748f02){#F2}

Comparison with ONS data {#s3h}
------------------------

The number of infants known to have survived to 28 days among admissions of infants born 22^+0^--31^+6^ weeks^+days^ GA recorded in the NNRD for England in 2013 was 6812. This represents 97% (6812/7027) of infants surviving to 28 days recorded by the ONS. There were 538 deaths before 28 days recorded for neonatal admissions in the NNRD, representing 64% (538/845) of deaths among live births in the ONS data. Most of the discrepancy occurred at earlier gestations; there were three survivors and nine deaths among admissions of infants at 22 weeks' GA in the NNRD, compared with 14 survivors and 130 deaths in the ONS ([table 3](#T3){ref-type="table"} shows the corresponding numbers for each GA week). The number of NNRD admissions as a percentage of ONS live births of infants 23^+0^--31^+6^ weeks^+days^ GA was 89% for the Midlands and East of England, 91% for London, 89% for the South of England and 92% for the North of England in 2013. [Table 3](#T3){ref-type="table"} shows corresponding numbers for each GA week; there were no clear patterns indicating regional differences in the proportion of live births admitted to neonatal care.

###### 

Comparison of NNRD (all admissions to neonatal care among births in England in 2013) and ONS (all live births in England in 2013)

                   Survival status\*   Region of mother's residence\*                                                      
  ---------------- ------------------- -------------------------------- ---------------- ---------------- ---------------- ----------------
  22^+0^--22^+6^   3/14 (21)           9/130 (7)                        †                †                †                †
  23^+0^--23^+6^   105/104 (101)       81/168 (48)                      44/57 (77)       52/77 (68)       51/79 (65)       31/57 (54)
  24^+0^--24^+6^   274/298 (92)        109/158 (69)                     79/108 (73)      93/109 (85)      110/134 (82)     80/105 (76)
  25^+0^--25^+6^   375/388 (97)        82/86 (95)                       88/95 (93)       118/136 (87)     134/136 (99)     102/106 (96)
  26^+0^--26^+6^   506/526 (96)        60/77 (78)                       126/134 (94)     165/189 (87)     146/164 (89)     105/115 (91)
  27^+0^--27^+6^   619/646 (96)        49/54 (91)                       115/130 (88)     184/202 (91)     194/199 (97)     144/164 (88)
  28^+0^--28^+6^   852/865 (98)        59/60 (98)                       173/192 (90)     248/268 (93)     221/242 (91)     208/221 (94)
  29^+0^--29^+6^   1049/1069 (98)      34/41 (83)                       194/198 (98)     300/334 (90)     311/342 (91)     221/236 (94)
  30^+0^--30^+6^   1306/1351 (97)      28/32 (88)                       247/261 (95)     371/412 (90)     371/384 (97)     275/324 (85)
  31^+0^--31^+6^   1723/1766 (98)      27/39 (69)                       349/376 (93)     449/496 (91)     462/491 (94)     405/436 (93)
  Total            6812/7027 (97)      538/845 (64)                     1415/1551 (91)   1980/2223 (89)   2000/2171 (92)   1571/1764 (89)

\*There were 17 infants in the NNRD with unknown survival status and 389 with unknown region of mother's residence so row totals may not correspond.

†Live births at 22 weeks' gestational age by region was not published.

‡There were 2256 live births in ONS data where gestational age data could not be linked or were not recorded.

NNRD, National Neonatal Research Database; ONS, Office of National Statistics.

Predictive model {#s3i}
----------------

Results from the logistic regression model are shown in online [supplementary table 1](#SP1){ref-type="supplementary-material"}. The survival predictions are illustrated in online [supplementary figures 1--8](#SP1){ref-type="supplementary-material"}. The model predicted well, with an area under the receiver operating characteristic curve of 0.84 (see online [supplementary material](#SP1){ref-type="supplementary-material"} for further performance statistics).

Discussion {#s4}
==========

We identify continuing improvement in the survival of very preterm infants admitted to neonatal care in England, from 1995 to the present, with the greatest increase in the most immature infants. Of note, there is evidence of a north-south divide, and persisting regional variation after adjustment for infant characteristics and socioeconomic differences.

A key strength is that over 50 000 very preterm infants were included, representing almost all neonatal admissions in the country during the period. A novel strength is the use of the NNRD, a repository of point-of-care, EPR-derived data, facilitating up-to-date assessment of neonatal outcomes. The estimated survival probabilities, based on near-contemporaneous data, can help guide discussions with parents, noting however the need to emphasise that these relate not to total live births, but to infants admitted to intensive care, and are valuable information for clinicians, managers and commissioners. Validation of the prediction model using a future cohort would confirm its applicability; such a cohort can be easily established from new admissions in the NNRD. The risk adjustment variables were important, unambiguous clinical characteristics, also obtained from the NNRD. We took several steps to limit or investigate potential bias and conclusions remained valid following a number of sensitivity analyses. Around 3.4% of infants had missing outcome data, which could bias the assessment of survival trends. Outcomes were missing due to transfer to a neonatal unit or specialist surgical provider not contributing data to the NNRD. While the number of neonatal units contributing increased over time, sensitivity analysis including only providers contributing data throughout the period yielded similar results. A limitation is that live-born infants who died before admission to neonatal care were not included. This is illustrated by the lower number of deaths of admitted infants recorded in the NNRD compared with deaths among live births in the ONS, largely at the earliest gestations. This limitation was unavoidable as data capture is triggered by neonatal unit admission. Changes in survival of admitted infants could result from changes in admission practices over time. Although such changes could not be ascertained from the data available, trends persisted after adjustment for key risk factors. However the similarity with ONS data for the number of infants surviving to 28 days provides reassurance on population completeness for admitted infants. Regional variation could be attributable to differences in criteria for active management of extremely preterm infants. If the southern regions have higher survival because the sickest infants are less likely to be admitted for active care, we would expect a lower proportion of live births to be admitted in these regions. Comparison of regional ONS and NNRD data showed no such pattern, although regional ONS data on infants born at 22 weeks' GA were unavailable.

Our study covers the entire population of neonatal admissions in a geographically defined region. This contrasts with previous reports such as those from the US National Institute of Child Health and Human Development Neonatal Research Network that focus on admissions to tertiary neonatal units,[@R16] a bias that may predispose to exaggerated estimates of survival. Nonetheless, survival rates were similar; in our study survival to discharge for infants at 24 weeks in 2014 was 66%, compared with the 65% survival in 2012 reported in a US tertiary neonatal unit admission study.[@R16] This survival rate was also similar to the 59% found in a population-based regional study of admitted infants born over 2007--2011 in Australia.[@R18] In contrast in 2011, the French EPIPAGE-2 study including all live births showed 31% survival to discharge.[@R19] However it should be noted that inclusion of all live births does not guarantee a consistent population, as shown by the variation across England in whether infants less than 24 weeks who die shortly after birth are in fact registered as live births.[@R20]

Our study has several implications for clinicians, policy makers and researchers. First, although not evidenced by published data to date, continued improvement in survival of very preterm infants may lead in future to a growing number of children and adults with long-term health needs. Opportunity for cost-effective long-term ascertainment of outcomes for all infants admitted to neonatal care is offered by linkage of NNRD data with other national records, such as hospital, general practice and educational data sets. Second, the improvement in survival appears to be largely at lower GA and was inconsistent across the regions. Identifying and reducing inequity in health outcomes are a stated intention of the UK Government and NHS England. Third, we show that NNRD data, derived from EPR, enable timely evaluations of outcomes and eliminate the need for separate data capture by busy clinical teams. The small number of very preterm births and the increasing rarity of death in this population mean that large sample sizes enabled by the national coverage of the NNRD are required to detect variation. There is considerable interest in using EPR for research; we hope our study will serve as a template to advance this approach to improve patient care.
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